Increasingly patients are learning about Wegovy and other GLP-1 drugs due to their potential role in body composition changes. Originally designed to address type 2 diabetes , these compounds function by imitating a body's substance that influences hunger and delays gastric motility . This two-pronged approach can lead to significant weight reduct